{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T14:50:40Z","timestamp":1767451840013,"version":"build-2065373602"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770223","82171726"],"award-info":[{"award-number":["81770223","82171726"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Provincial Medical Key Discipline","award":["JSDW202213"],"award-info":[{"award-number":["JSDW202213"]}]},{"name":"Construction Project of High Level Hospital of Jiangsu Province","award":["GSPJS202414","GSPJS202417","GSPJS202420"],"award-info":[{"award-number":["GSPJS202414","GSPJS202417","GSPJS202420"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07098-7","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:30:48Z","timestamp":1761042648000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single-cell transcriptomics identifies PDIA4 as a marker of progression and therapeutic vulnerability in multiple myeloma"],"prefix":"10.1186","volume":"23","author":[{"given":"Wenjie","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiamin","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aoyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuexuan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunv","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5588-7824","authenticated-orcid":false,"given":"Chong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4610-9135","authenticated-orcid":false,"given":"Zhenyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"7098_CR1","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/ajh.27422","volume":"99","author":"SV Rajkumar","year":"2024","unstructured":"Rajkumar SV. Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol. 2024;99:1802\u201324.","journal-title":"Am J Hematol"},{"key":"7098_CR2","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","volume":"111","author":"RA Kyle","year":"2008","unstructured":"Kyle RA, Rajkumar SV. Multiple myeloma. Blood. 2008;111:2962\u201372.","journal-title":"Blood"},{"key":"7098_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1146\/annurev-pathol-011110-130249","volume":"6","author":"KC Anderson","year":"2011","unstructured":"Anderson KC, Carrasco RD. Pathogenesis of myeloma. Annu Rev Pathol. 2011;6:249\u201374.","journal-title":"Annu Rev Pathol"},{"key":"7098_CR4","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1038\/s41375-020-01051-x","volume":"34","author":"M Ho","year":"2020","unstructured":"Ho M, Patel A, Goh CY, Moscvin M, Zhang L, Bianchi G. Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). Leukemia. 2020;34:3111\u201325.","journal-title":"Leukemia"},{"key":"7098_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2025.104268","volume":"54","author":"C Saade","year":"2025","unstructured":"Saade C, Ghobrial IM. Updates on mechanisms of disease progression in precursor myeloma: Monoclonal gammopathy of undermined significance and smoldering myeloma. Presse Med. 2025;54:104268.","journal-title":"Presse Med"},{"key":"7098_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s43556-024-00188-w","volume":"5","author":"Q Lu","year":"2024","unstructured":"Lu Q, Yang D, Li H, Niu T, Tong A. Multiple myeloma: signaling pathways and targeted therapy. Mol Biomed. 2024;5:25.","journal-title":"Mol Biomed"},{"key":"7098_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2024.101242","volume":"68","author":"G Hevroni","year":"2024","unstructured":"Hevroni G, Vattigunta M, Kazandjian D, Coffey D, Diamond B, Maura F, et al. From MGUS to multiple myeloma: unraveling the unknown of precursor states. Blood Rev. 2024;68:101242.","journal-title":"Blood Rev"},{"key":"7098_CR8","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1182\/hematology.2021000303","volume":"2021","author":"O Landgren","year":"2021","unstructured":"Landgren O. Advances in MGUS diagnosis, risk stratification, and management: introducing myeloma-defining genomic events. Hematology Am Soc Hematol Educ Program. 2021;2021:662\u201372.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"7098_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11091534","author":"A Salomon-Perzy\u0144ski","year":"2021","unstructured":"Salomon-Perzy\u0144ski A, Jamroziak K, G\u0142odkowska-Mr\u00f3wka E. Clonal evolution of multiple myeloma-clinical and diagnostic implications. Diagnostics (Basel). 2021. https:\/\/doi.org\/10.3390\/diagnostics11091534.","journal-title":"Diagnostics (Basel)"},{"key":"7098_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41571-021-00593-y","volume":"19","author":"AK Dutta","year":"2022","unstructured":"Dutta AK, Alberge JB, Sklavenitis-Pistofidis R, Lightbody ED, Getz G, Ghobrial IM. Single-cell profiling of tumour evolution in multiple myeloma - opportunities for precision medicine. Nat Rev Clin Oncol. 2022;19:223\u201336.","journal-title":"Nat Rev Clin Oncol"},{"key":"7098_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nri.2017.76","volume":"18","author":"E Papalexi","year":"2018","unstructured":"Papalexi E, Satija R. Single-cell RNA sequencing to explore immune cell heterogeneity. Nat Rev Immunol. 2018;18:35\u201345.","journal-title":"Nat Rev Immunol"},{"key":"7098_CR12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1182\/blood.2024025231","volume":"145","author":"DG Coffey","year":"2025","unstructured":"Coffey DG, Ataca Atilla P, Atilla E, Landgren O, Cowan AJ, Simon S, et al. Single-cell analysis of the multiple myeloma microenvironment after \u03b3-secretase inhibition and CAR T-cell therapy. Blood. 2025;145:220\u201333.","journal-title":"Blood"},{"key":"7098_CR13","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1007\/s00018-021-03756-3","volume":"78","author":"S Xiong","year":"2021","unstructured":"Xiong S, Chng WJ, Zhou J. Crosstalk between endoplasmic reticulum stress and oxidative stress: a dynamic duo in multiple myeloma. Cell Mol Life Sci. 2021;78:3883\u2013906.","journal-title":"Cell Mol Life Sci"},{"key":"7098_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215340","author":"G Wang","year":"2022","unstructured":"Wang G, Fan F, Sun C, Hu Y. Looking into endoplasmic reticulum stress: the key to drug-resistance of multiple myeloma? Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14215340.","journal-title":"Cancers (Basel)"},{"key":"7098_CR15","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1158\/1535-7163.MCT-12-0782","volume":"12","author":"L Vincenz","year":"2013","unstructured":"Vincenz L, J\u00e4ger R, O\u2019Dwyer M, Samali A. Endoplasmic reticulum stress and the unfolded protein response: targeting the Achilles heel of multiple myeloma. Mol Cancer Ther. 2013;12:831\u201343.","journal-title":"Mol Cancer Ther"},{"key":"7098_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409219","volume":"12","author":"J Xu","year":"2025","unstructured":"Xu J, Dong X, Peng Y, Yan J, Xu P, Li F, et al. ZMYND8 reads H3K36me2 to activate CEBPE transcription and suppress multiple myeloma progression through the inhibition of adaptive UPR pathways. Adv Sci (Weinh). 2025;12:e2409219.","journal-title":"Adv Sci (Weinh)"},{"key":"7098_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109688","volume":"122","author":"Z Wang","year":"2020","unstructured":"Wang Z, Zhang H, Cheng Q. PDIA4: the basic characteristics, functions and its potential connection with cancer. Biomed Pharmacother. 2020;122:109688.","journal-title":"Biomed Pharmacother"},{"key":"7098_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s43018-020-0053-3","volume":"1","author":"O Zavidij","year":"2020","unstructured":"Zavidij O, Haradhvala NJ, Mouhieddine TH, Sklavenitis-Pistofidis R, Cai S, Reidy M, et al. Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma. Nat Cancer. 2020;1:493\u2013506.","journal-title":"Nat Cancer"},{"key":"7098_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36:411\u201320.","journal-title":"Nat Biotechnol"},{"key":"7098_CR20","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1158\/1078-0432.CCR-24-0352","volume":"30","author":"Y Yang","year":"2024","unstructured":"Yang Y, Qin S, Yang M, Wang T, Feng R, Zhang C, et al. Reconstitution of the multiple myeloma microenvironment following lymphodepletion with BCMA CAR-T therapy. Clin Cancer Res. 2024;30:4201\u201314.","journal-title":"Clin Cancer Res"},{"key":"7098_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.757","volume":"12","author":"H He","year":"2022","unstructured":"He H, Li Z, Lu J, Qiang W, Jiang S, Xu Y, et al. Single-cell RNA-seq reveals clonal diversity and prognostic genes of relapsed multiple myeloma. Clin Transl Med. 2022;12:e757.","journal-title":"Clin Transl Med"},{"key":"7098_CR22","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ymthe.2020.11.028","volume":"29","author":"X Li","year":"2021","unstructured":"Li X, Guo X, Zhu Y, Wei G, Zhang Y, Li X, et al. Single-cell transcriptomic analysis reveals BCMA CAR-T cell dynamics in a patient with refractory primary plasma cell leukemia. Mol Ther. 2021;29:645\u201357.","journal-title":"Mol Ther"},{"key":"7098_CR23","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1016\/j.cell.2021.11.017","volume":"184","author":"S Raghavan","year":"2021","unstructured":"Raghavan S, Winter PS, Navia AW, Williams HL, DenAdel A, Lowder KE, et al. Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. Cell. 2021;184:6119\u201337.","journal-title":"Cell"},{"issue":"1","key":"7098_CR24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/biom13010078","volume":"13","author":"Z Fang","year":"2022","unstructured":"Fang Z, Li J, Cao F, Li F. Integration of scRNA-seq and bulk RNA-seq reveals molecular characterization of the immune microenvironment in acute pancreatitis. Biomolecules. 2022;13(1):78.","journal-title":"Biomolecules"},{"key":"7098_CR25","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1186\/gb-2014-15-3-r47","volume":"15","author":"P Geeleher","year":"2014","unstructured":"Geeleher P, Cox NJ, Huang RS. Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines. Genome Biol. 2014;15:R47.","journal-title":"Genome Biol"},{"key":"7098_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab260","author":"D Maeser","year":"2021","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021. https:\/\/doi.org\/10.1093\/bib\/bbab260.","journal-title":"Brief Bioinform"},{"key":"7098_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1053\/j.seminoncol.2022.01.006","volume":"49","author":"M Chojnacka","year":"2022","unstructured":"Chojnacka M, Diamond B, Landgren O, Maura F. Defining genomic events involved in the evolutionary trajectories of myeloma and its precursor conditions. Semin Oncol. 2022;49:11\u20138.","journal-title":"Semin Oncol"},{"key":"7098_CR28","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1056\/NEJMoa070389","volume":"356","author":"RA Kyle","year":"2007","unstructured":"Kyle RA, Remstein ED, Therneau TM, Dispenzieri A, Kurtin PJ, Hodnefield JM, et al. Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med. 2007;356:2582\u201390.","journal-title":"N Engl J Med"},{"key":"7098_CR29","doi-asserted-by":"publisher","first-page":"e730","DOI":"10.1002\/ctm2.730","volume":"12","author":"H Jiang","year":"2022","unstructured":"Jiang H, Yu D, Yang P, Guo R, Kong M, Gao Y, et al. Revealing the transcriptional heterogeneity of organ-specific metastasis in human gastric cancer using single-cell RNA sequencing. Clin Transl Med. 2022;12:e730.","journal-title":"Clin Transl Med"},{"key":"7098_CR30","doi-asserted-by":"publisher","first-page":"e1007","DOI":"10.1002\/cti2.1007","volume":"7","author":"N Nikesitch","year":"2018","unstructured":"Nikesitch N, Lee JM, Ling S, Roberts TL. Endoplasmic reticulum stress in the development of multiple myeloma and drug resistance. Clin Transl Immunol. 2018;7:e1007.","journal-title":"Clin Transl Immunol"},{"key":"7098_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fgene.2013.00109","volume":"4","author":"S White-Gilbertson","year":"2013","unstructured":"White-Gilbertson S, Hua Y, Liu B. The role of endoplasmic reticulum stress in maintaining and targeting multiple myeloma: a double-edged sword of adaptation and apoptosis. Front Genet. 2013;4:109.","journal-title":"Front Genet"},{"key":"7098_CR32","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/S0140-6736(14)60493-1","volume":"385","author":"C R\u00f6llig","year":"2015","unstructured":"R\u00f6llig C, Knop S, Bornh\u00e4user M. Multiple myeloma. Lancet. 2015;385:2197\u2013208.","journal-title":"Lancet"},{"key":"7098_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fcell.2019.00050","volume":"7","author":"A Serrano-Del Valle","year":"2019","unstructured":"Serrano-Del Valle A, Anel A, Naval J, Marzo I. Immunogenic cell death and immunotherapy of multiple myeloma. Front Cell Dev Biol. 2019;7:50.","journal-title":"Front Cell Dev Biol"},{"key":"7098_CR34","doi-asserted-by":"publisher","first-page":"889954","DOI":"10.3389\/fimmu.2022.889954","volume":"13","author":"KR Hamedi","year":"2022","unstructured":"Hamedi KR, Harmon KA, Goodwin RL, Arce S. Autophagy and the bone marrow microenvironment: a review of protective factors in the development and maintenance of multiple myeloma. Front Immunol. 2022;13:889954.","journal-title":"Front Immunol"},{"key":"7098_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2015.04.002","volume":"33","author":"F Tameire","year":"2015","unstructured":"Tameire F, Verginadis II, Koumenis C. Cell intrinsic and extrinsic activators of the unfolded protein response in cancer: mechanisms and targets for therapy. Semin Cancer Biol. 2015;33:3\u201315.","journal-title":"Semin Cancer Biol"},{"key":"7098_CR36","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/10428190500312196","volume":"47","author":"M Nakamura","year":"2006","unstructured":"Nakamura M, Gotoh T, Okuno Y, Tatetsu H, Sonoki T, Uneda S, et al. Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cells. Leuk Lymphoma. 2006;47:531\u20139.","journal-title":"Leuk Lymphoma"},{"issue":"24","key":"7098_CR37","doi-asserted-by":"publisher","first-page":"9351","DOI":"10.3390\/ijms21249351","volume":"21","author":"S Kanemura","year":"2020","unstructured":"Kanemura S, Matsusaki M, Inaba K, Okumura M. PDI family members as guides for client folding and assembly. Int J Mol Sci. 2020;21(24):9351.","journal-title":"Int J Mol Sci"},{"key":"7098_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.placenta.2017.04.007","volume":"53","author":"AL Winship","year":"2017","unstructured":"Winship AL, Sorby K, Correia J, Rainczuk A, Yap J, Dimitriadis E. Interleukin-11 up-regulates endoplasmic reticulum stress induced target, PDIA4 in human first trimester placenta and in vivo in mice. Placenta. 2017;53:92\u2013100.","journal-title":"Placenta"},{"key":"7098_CR39","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.dld.2014.05.013","volume":"46","author":"A Negroni","year":"2014","unstructured":"Negroni A, Prete E, Vitali R, Cesi V, Aloi M, Civitelli F, et al. Endoplasmic reticulum stress and unfolded protein response are involved in paediatric inflammatory bowel disease. Dig Liver Dis. 2014;46:788\u201394.","journal-title":"Dig Liver Dis"},{"key":"7098_CR40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41419-023-05719-x","volume":"14","author":"L Kang","year":"2023","unstructured":"Kang L, Wang D, Shen T, Liu X, Dai B, Zhou D, et al. PDIA4 confers resistance to ferroptosis via induction of ATF4\/SLC7A11 in renal cell carcinoma. Cell Death Dis. 2023;14:193.","journal-title":"Cell Death Dis"},{"key":"7098_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.mce.2015.11.005","volume":"422","author":"L Yu","year":"2016","unstructured":"Yu L, Andruska N, Zheng X, Shapiro DJ. Anticipatory activation of the unfolded protein response by epidermal growth factor is required for immediate early gene expression and cell proliferation. Mol Cell Endocrinol. 2016;422:31\u201341.","journal-title":"Mol Cell Endocrinol"},{"key":"7098_CR42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12974-019-1429-0","volume":"16","author":"S Xu","year":"2019","unstructured":"Xu S, Di Z, He Y, Wang R, Ma Y, Sun R, et al. Mesencephalic astrocyte-derived neurotrophic factor (MANF) protects against A\u03b2 toxicity via attenuating A\u03b2-induced endoplasmic reticulum stress. J Neuroinflammation. 2019;16:35.","journal-title":"J Neuroinflammation"},{"key":"7098_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123125","volume":"358","author":"O Sogbein","year":"2024","unstructured":"Sogbein O, Paul P, Umar M, Chaari A, Batuman V, Upadhyay R. Bortezomib in cancer therapy: mechanisms, side effects, and future proteasome inhibitors. Life Sci. 2024;358:123125.","journal-title":"Life Sci"},{"key":"7098_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075280","volume":"8","author":"S Manni","year":"2013","unstructured":"Manni S, Brancalion A, Mandato E, Tubi LQ, Colpo A, Pizzi M, et al. Protein kinase CK2 inhibition down modulates the NF-\u03baB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells. PLoS ONE. 2013;8:e75280.","journal-title":"PLoS ONE"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07098-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07098-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07098-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:03:56Z","timestamp":1761087836000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07098-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7098"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07098-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"type":"electronic","value":"1479-5876"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in strict accordance with established guidelines. The experimental protocol was formally approved by the Experimental Animal Ethics Committee of Xuzhou Medical University (Xuzhou, China), under IACUC Issue No. 202312T042.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1136"}}